BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10686034)

  • 1. Evidence for the diagnosis of pancreatic insufficiency.
    Borowitz D
    Pediatr Pulmonol; 2000 Mar; 29(3):167-8. PubMed ID: 10686034
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.
    Cade A; Walters MP; McGinley N; Firth J; Brownlee KG; Conway SP; Littlewood JM
    Pediatr Pulmonol; 2000 Mar; 29(3):172-6. PubMed ID: 10686036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.
    Walkowiak J; Sands D; Nowakowska A; Piotrowski R; Zybert K; Herzig KH; Milanowski A
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):199-201. PubMed ID: 15699697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal elastase-1 (EL-1) in pediatric patients with cystic fibrosis.
    Wiwanitkit V
    J Pediatr (Rio J); 2011 May-Jun 8; 87(3):273; author reply 273. PubMed ID: 21660372
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency.
    Walkowiak J; Herzig KH; Witt M; Pogorzelski A; Piotrowski R; Barra E; Sobczynska-Tomaszewska A; Trawinska-Bartnicka M; Strzykala K; Cichy W; Sands D; Rutkiewicz E; Krawczynski M
    Eur J Clin Invest; 2001 Sep; 31(9):796-801. PubMed ID: 11589722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoclonal faecal elastase-1 concentration for pancreatic status assessment in cystic fibrosis patients.
    Gonzales AC; Vieira SM; Maurer RL; Silva FA; Silveira TR
    J Pediatr (Rio J); 2011; 87(2):157-62. PubMed ID: 21503378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis.
    Walkowiak J; Herzig KH; Strzykala K; Przyslawski J; Krawczynski M
    Pediatrics; 2002 Jul; 110(1 Pt 1):e7. PubMed ID: 12093988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of fecal elastase 1 in diagnosis of the external secretion of the pancreas].
    Parunian LM
    Lik Sprava; 2003 Dec; (8):44-6. PubMed ID: 14965004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of faecal lipase test and faecal elastase-1 test in the assessment of exocrine pancreatic function in cystic fibrosis].
    Walkowiak J; Herzig KH; Strzykala K; Lisowska A; Przyslawski J; Grzymislawski M; Krawczynski M
    Med Wieku Rozwoj; 2003; 7(2):149-55. PubMed ID: 12878785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited causes of exocrine pancreatic insufficiency in pediatric patients: clinical presentation and laboratory testing.
    Yuzyuk TN; Nelson HA; Johnson LM
    Crit Rev Clin Lab Sci; 2023 Aug; 60(5):366-381. PubMed ID: 36876586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study.
    Weintraub A; Blau H; Mussaffi H; Picard E; Bentur L; Kerem E; Stankiewicz H; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):306-10. PubMed ID: 19274786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and follow up of exocrine pancreatic insufficiency in cystic fibrosis: a review.
    Leus J; Van Biervliet S; Robberecht E
    Eur J Pediatr; 2000 Aug; 159(8):563-8. PubMed ID: 10968231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the evaluation of pancreatic exocrine status in cystic fibrosis.
    Borowitz D
    Curr Opin Pulm Med; 2005 Nov; 11(6):524-7. PubMed ID: 16217179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test.
    Walkowiak J; Nousia-Arvanitakis S; Agguridaki C; Fotoulaki M; Strzykala K; Balassopoulou A; Witt M; Herzig KH
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):474-8. PubMed ID: 12658038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis.
    Dalzell AM; Heaf DP
    Arch Dis Child; 1990 Jul; 65(7):788-9. PubMed ID: 2386387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern methods for detecting exocrine pancreas insufficiency in mucoviscidosis].
    Fischer B; Löhr M; Hahn EG; Liebe S
    Pneumologie; 1996 Dec; 50 Suppl 3():812-4. PubMed ID: 9157432
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal versus polyclonal ELISA for assessment of fecal elastase concentration: pitfalls of a new assay.
    Schneider A; Funk B; Caspary W; Stein J
    Clin Chem; 2005 Jun; 51(6):1052-4. PubMed ID: 15845804
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolution of pancreatic function during the first year in infants with cystic fibrosis.
    O'Sullivan BP; Baker D; Leung KG; Reed G; Baker SS; Borowitz D
    J Pediatr; 2013 Apr; 162(4):808-812.e1. PubMed ID: 23245194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal elastase-1 concentration: an indirect test of exocrine pancreatic function and a marker of an enteropathy regardless of cause.
    Nousia-Arvanitakis S
    J Pediatr Gastroenterol Nutr; 2003 Mar; 36(3):314-5. PubMed ID: 12604968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.